The Personalisation of Glioblastoma Treatment Using Whole Exome Sequencing: A Pilot Study
The molecular heterogeneity of glioblastoma has been linked to differences in survival and treatment response, while the development of personalised treatments may be a novel way of combatting this disease. Here we show for the first time that low passage number cells derived from primary tumours ar...
Main Authors: | Anne-Marie Garrett, Sarah Lastakchi, Christopher McConville |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-02-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/2/173 |
Similar Items
-
Whole Exome Sequencing of Chronic Myeloid Leukemia Patients
by: Shaghayegh SABRI, et al.
Published: (2016-03-01) -
Patterns of Whole Exome Sequencing in Resected Cholangiocarcinoma
by: Lucas W. Thornblade, et al.
Published: (2021-08-01) -
A Novel Non-frameshift ADA Deletion Detected by Whole Exome Sequencing in an Iranian Family with Severe Combined Immunodeficiency
by: Taravat Talebi, et al.
Published: (2020-02-01) -
Whole exome sequencing of a patient with metastatic hidradenocarcinoma and review of the literature
by: Eva Gupta, et al.
Published: (2015-02-01) -
Comprehensive Outline of Whole Exome Sequencing Data Analysis Tools Available in Clinical Oncology
by: Áron Bartha, et al.
Published: (2019-11-01)